2018
DOI: 10.1182/bloodadvances.2018026344
|View full text |Cite
|
Sign up to set email alerts
|

Lee J, Zhang LL, Wu W, et al. Activation of MYC, a bona fide client of HSP90, contributes to intrinsic ibrutinib resistance in mantle cell lymphoma. Blood Adv. 2018;2(16):2039-2051.

Abstract: developed the assays, designed and performed the experiments, solved technical problems, and analyzed the data; M.A. participated in IHC review and data presentation; L.

Help me understand this report

This publication either has no citations yet, or we are still processing them

Set email alert for when this publication receives citations?

See others like this or search for similar articles